{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:14:02Z","timestamp":1768468442782,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.remnie.2025.500272","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:49:49Z","timestamp":1767372589000},"page":"500272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of [18F]F-choline PET\/CT on the management of high-risk prostate cancer"],"prefix":"10.1016","author":[{"given":"C.","family":"Cases-Pellis\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Villa Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"\u00c1lvarez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Trivi\u00f1o-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Brero S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pach\u00f3n Garrudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Cejudo Li\u00e9bana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"S\u00e1nchez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Jim\u00e9nez-Hoyuela Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Freire-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2025.500272_bib0005","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.remnie.2025.500272_bib0010","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.remnie.2025.500272_bib0015","unstructured":"Prostate Cancer \u2014 Cancer Stat Facts Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html (accessed on 14 November 2025)."},{"key":"10.1016\/j.remnie.2025.500272_bib0020","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"31","author":"Parker","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remnie.2025.500272_bib0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.56434\/j.arch.esp.urol.20227508.99","article-title":"Role of 18F-Choline PET\/CT in the initial staging of high risk prostate cancer and comparison with conventional imaging techniques","volume":"75","author":"Sope\u00f1a Sutil","year":"2022","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.remnie.2025.500272_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2013.04.019","article-title":"The role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Umbehr","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2025.500272_bib0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer, version 2.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.remnie.2025.500272_bib0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.remnie.2025.500272_bib0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2025.500272_bib0050","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2967\/jnumed.123.267355","article-title":"A prospective randomized multicenter study on the impact of [18F]F-Choline PET\/CT versus conventional imaging for staging intermediate- to high-risk prostate cancer","volume":"65","author":"Evangelista","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500272_bib0055","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00256-014-1903-9","article-title":"Comparison of Choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis","volume":"43","author":"Shen","year":"2014","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.remnie.2025.500272_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","article-title":"Head-to-Head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for initial staging of intermediate- to high-risk prostate cancer: a systematic review and meta-anal\u2026","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.remnie.2025.500272_bib0065","doi-asserted-by":"crossref","first-page":"205.e17","DOI":"10.1016\/j.urolonc.2022.12.006","article-title":"A prospective, multicenter Head-to-Head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET\/CT","volume":"41","author":"Bodar","year":"2023","journal-title":"Urol Oncol: Semin Original Invest"},{"key":"10.1016\/j.remnie.2025.500272_bib0070","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12094-018-1985-2","article-title":"Diagnostic performance of 18F-Choline PET-CT in prostate cancer","volume":"21","author":"Samper Ots","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.remnie.2025.500272_bib0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1148\/radiol.09090413","article-title":"18F Choline PET0\/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients","volume":"254","author":"Beheshti","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.remnie.2025.500272_bib0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/21681805.2015.1005665","article-title":"Comparison between Conventional Imaging (Abdominal-Pelvic Computed Tomography and Bone Scan) and [(18)F]Choline Positron Emission Tomography\/Computed Tomography Imaging for the Initial Staging of Patients with Intermediate- Tohigh-Risk Prostate Cancer: A\u2026","volume":"49","author":"Evangelista","year":"2015","journal-title":"Scand J Urol"},{"key":"10.1016\/j.remnie.2025.500272_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102463","article-title":"The role of [18F]F-Choline PET\/CT in the initial management and outcome prediction of prostate cancer: a real-world experience from a multidisciplinary approach","volume":"10","author":"Urso","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.remnie.2025.500272_bib0090","first-page":"223","article-title":"18F-F-Choline PET\/CT in staging of newly diagnosed high-risk prostate cancer","volume":"45","author":"Benameur","year":"2021","journal-title":"M\u00e9d Nucl"},{"key":"10.1016\/j.remnie.2025.500272_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2020.151044","article-title":"PSMA PET Scan Era: A Changing Paradigm PSMA PET and Lymph Node Dissection for Prostate Cancer Management","volume":"36","author":"Haxhimolla","year":"2020","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.remnie.2025.500272_bib0100","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00259-021-05210-9","article-title":"Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis","volume":"48","author":"Alberts","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500272_bib0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/RLU.0000000000002526","article-title":"Comparing the staging\/restaging performance of 68Ga-labeled prostate-specific membrane antigen and 18F-Choline PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"44","author":"Lin","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remnie.2025.500272_bib0110","article-title":"The diagnostic role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET\/CT in the detection of prostate cancer with biochemical recurrence: a meta-analysis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.remnie.2025.500272_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050710","article-title":"Detection rate of 18 F-Labeled PSMA PET\/CT in biochemical recurrent prostate cancer: a systematic review and a meta-analysis","volume":"11","author":"Treglia","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:10:55Z","timestamp":1768425055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"alternative-id":["S2253808925001788"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500272","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of [18F]F-choline PET\/CT on the management of high-risk prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular.","name":"copyright","label":"Copyright"}],"article-number":"500272"}}